Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease

Gastroenterology Research and Practice

Volumn , Issue , 2010, Pages

  Miura, Kouichi ^a   Seki, Ekihiro ^b   Ohnishi, Hirohide ^a   Brenner, David A ^b  

^a AKITA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PARACETAMOL; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BACTERIAL OVERGROWTH; CELL SURVIVAL; GASTROINTESTINAL TRACT; GUT LIVER AXIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; KUPFFER CELL; LIPOGENESIS; LIVER CELL; LIVER INJURY; METABOLIC SYNDROME X; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 79952230506     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2010/362847     Document Type: Review

References (103)

1. Marra F., Gastaldelli A., Svegliati Baroni G., Tell G., Tiribelli C., Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis Trends in Molecular Medicine 2008 14 2 72 81
2. Ludwig J., Viggiano T. R., McGill D. B., Ott B. J., Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto (Pubitemid 10057164)
3. Hilden M., Christoffersen P., Juhl E., Dalgaard J. B., Liver histology in a 'normal' populationexaminations of 503 consecutive fatal traffic casualties Scandinavian Journal of Gastroenterology 1977 12 5 593 597 (Pubitemid 8149779)
4. Nomura H., Kashiwagi S., Hayashi J., Kajiyama W., Tani S., Goto M., Prevalence of fatty liver in a general population of Okinawa, Japan Japanese Journal of Medicine 1988 27 2 142 149
5. Bellentani S., Saccoccio G., Masutti F., Croc L. S., Brandi G., Sasso F., Cristanini G., Tiribelli C., Prevalence of and risk factors for hepatic steatosis in northern Italy Annals of Internal Medicine 2000 132 2 112 117 (Pubitemid 30044177)
6. Koteish A., Diehl A. M., Animal models of steatosis Seminars in Liver Disease 2001 21 1 89 104 (Pubitemid 32240489)
7. Bradbury M. W., Berk P. D., Lipid metabolism in hepatic steatosis Clinics in Liver Disease 2004 8 3 639 671 (Pubitemid 39141147)
8. Anstee Q. M., Goldin R. D., Mouse models in non-alcoholic fatty liver disease and steatohepatitis research International Journal of Experimental Pathology 2006 87 1 1 16
9. Bilzer M., Roggel F., Gerbes A. L., Role of Kupffer cells in host defense and liver disease Liver International 2006 26 10 1175 1186 (Pubitemid 44741204)
10. Seki E., Brenner D. A., Toll-like receptors and adaptor molecules in liver disease: update Hepatology 2008 48 1 322 335 (Pubitemid 351975556)
11. Baffy G., Kupffer cells in non-alcoholic fatty liver disease: the emerging view Journal of Hepatology 2009 51 1 212 223
12. Frank D. N., Amand A. L. St., Feldman R. A., Boedeker E. C., Harpaz N., Pace N. R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proceedings of the National Academy of Sciences of the United States of America 2007 104 34 13780 13785 (Pubitemid 350003397)
13. DiBaise J. K., Zhang H., Crowell M. D., Krajmalnik-Brown R., Decker G. A., Rittmann B. E., Gut microbiota and its possible relationship with obesity Mayo Clinic Proceedings 2008 83 4 460 469 (Pubitemid 351536471)
14. Tennyson C. A., Friedman G., Microecology, obesity, and probiotics Current Opinion in Endocrinology, Diabetes and Obesity 2008 15 5 422 427
15. Bckhed F., Ding H., Wang T., Hooper L. V., Gou Y. K., Nagy A., Semenkovich C. F., Gordon J. I., The gut microbiota as an environmental factor that regulates fat storage Proceedings of the National Academy of Sciences of the United States of America 2004 101 44 15718 15723 (Pubitemid 39473554)
16. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Pal G., Martines D., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis American Journal of Physiology 2007 292 2 G518 G525
17. Santacruz A., Marcos A., Wrnberg J., Mart A., Martin-Matillas M., Campoy C., Moreno L. A., Veiga O., Redondo-Figuero C., Garagorri J. M., Azcona C., Delgado M., Garca-Fuentes M., Collado M. C., Sanz Y., Interplay between weight loss and gut microbiota composition in overweight adolescents Obesity 2009 17 10 1906 1915
18. Larsen N., Vogensen F. K., van den Berg F. W. J., Nielsen D. S., Andreasen A. S., Pedersen B. K., Al-Soud W. A., Srensen S. J., Hansen L. H., Jakobsen M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS One 2010 5 2
19. Tsukumo D. M. L., Carvalho-Filho M. A., Carvalheira J. B. C., Prada P. O., Hirabara S. M., Schenka A. A., Arajo E. P., Vassallo J., Curi R., Velloso L. A., Saad M. J. A., Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance Diabetes 2007 56 8 1986 1998 (Pubitemid 47195825)
20. Rivera C. A., Adegboyega P., van Rooijen N., Tagalicud A., Allman M., Wallace M., Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis Journal of Hepatology 2007 47 4 571 579 (Pubitemid 47331747)
21. Spruss A., Kanuri G., Wagnerberger S., Haub S., Bischoff S. C., Bergheim I., Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 2009 50 4 1094 1104
22. Kodama Y., Kisseleva T., Iwaisako K., Miura K., Taura K., De Minicis S., sterreicher C. H., Schnabl B., Seki E., Brenner D. A., c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice Gastroenterology 2009 137 4 1467 1477.e5
23. Seki E., De Minicis S., sterreicher C. H., Kluwe J., Osawa Y., Brenner D. A., Schwabe R. F., TLR4 enhances TGF- signaling and hepatic fibrosis Nature Medicine 2007 13 11 1324 1332 (Pubitemid 350073596)
24. Imaeda A. B., Watanabe A., Sohail M. A., Mahmood S., Mohamadnejad M., Sutterwala F. S., Flavell R. A., Mehal W. Z., Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome Journal of Clinical Investigation 2009 119 2 305 314
25. Szabo G., Velayudham A., Romics L. Jr., Mandrekar P., Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4 Alcoholism: Clinical and Experimental Research 2005 29 11 140S 145S (Pubitemid 43194341)
26. Miura K., Kodama Y., Inokuchi S., Schnabl B., Aoyama T., Ohnishi H., Olefsky J. M., Brenner D. A., Seki E., Toll-like receptor 9 promotes steatohepatitis via induction of interleukin-1 in mice Gastroenterology 2010 139 1 323 334.e7
27. Pappo I., Becovier H., Berry E. M., Freund H. R., Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat Journal of Surgical Research 1991 51 2 106 112
28. Pappo I., Bercovier H., Berry E. M., Haviv Y., Gallily R., Freund H. R., Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide Journal of Parenteral and Enteral Nutrition 1992 16 6 529 532
29. Drenick E. J., Fisler J., Johnson D., Hepatic steatosis after intestinal bypassprevention and reversal by metronidazole, irrespective of protein-calorie malnutrition Gastroenterology 1982 82 3 535 548 (Pubitemid 12166814)
30. Cani P. D., Amar J., Iglesias M. A., Poggi M., Knauf C., Bastelica D., Neyrinck A. M., Fava F., Tuohy K. M., Chabo C., Waget A., Delme E., Cousin B., Sulpice T., Chamontin B., Ferrires J., Tanti J. F., Gibson G. R., Casteilla L., Delzenne N. M., Alessi M. C., Burcelin R., Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 2007 56 7 1761 1772 (Pubitemid 47025442)
31. Kudo H., Takahara T., Yata Y., Kawai K., Zhang W., Sugiyama T., Lipopolysaccharide triggered TNF- -induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model Journal of Hepatology 2009 51 1 168 175
32. Mathison J. C., Ulevitch R. J., The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits Journal of Immunology 1979 123 5 2133 2143 (Pubitemid 10194464)
33. Ruiter D. J., Van Der Meulen J., Brouwer A., Uptake by liver cell of endotoxin following its intravenous injection Laboratory Investigation 1981 45 1 38 45 (Pubitemid 11059989)
34. Kawai T., Akira S., The roles of TLRs, RLRs and NLRs in pathogen recognition International Immunology 2009 21 4 317 337
35. Guarner C., Gonzlez-Navajas J. M., Snchez E., Soriando G., Francs R., Chiva M., Zapater P., Benlloch S., Muoz C., Pascual S., Balanz J., Prez-Mateo M., Such J., The detection of bacterial DNA in blood of rats with CCl -induced cirrhosis with ascites represents episodes of bacterial translocation Hepatology 2006 44 3 633 639 (Pubitemid 44433719)
36. Francs R., Zapater P., Gonzlez-Navajas J. M., Muoz C., Cao R., Moreu R., Pascual S., Bellot P., Prez-Mateo M., Such J., Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis Hepatology 2008 47 3 978 985 (Pubitemid 351449689)
37. Caricilli A. M., Nascimento P. H., Pauli J. R., Tsukumo D. M. L., Velloso L. A., Carvalheira J. B., Saad M. J. A., Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet Journal of Endocrinology 2008 199 3 399 406
38. Himes R. W., Smith C. W., Tlr2 is critical for diet-induced metabolic syndrome in a murine model FASEB Journal 2010 24 3 731 739
39. Bjrkbacka H., Kunjathoor V. V., Moore K. J., Koehn S., Ordija C. M., Lee M. A., Means T., Halmen K., Luster A. D., Golenbock D. T., Freeman M. W., Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways Nature Medicine 2004 10 4 416 421 (Pubitemid 38508522)
40. Michelsen K. S., Wong M. H., Shah P. K., Zhang W., Yano J., Doherty T. M., Akira S., Rajavashisth T. B., Arditi M., Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E Proceedings of the National Academy of Sciences of the United States of America 2004 101 29 10679 10684 (Pubitemid 38955802)
41. Hirotani T., Yamamoto M., Kumagai Y., Uematsu S., Kawase I., Takeuchi O., Akira S., Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN- Biochemical and Biophysical Research Communications 2005 328 2 383 392 (Pubitemid 40208323)
42. Naugler W. E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A. M., Karin M., Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 2007 317 5834 121 124 (Pubitemid 47056470)
43. Senn J. J., Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes Journal of Biological Chemistry 2006 281 37 26865 26875 (Pubitemid 44401715)
44. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025 (Pubitemid 44684486)
45. Watanabe A., Hashmi A., Gomes D. A., Town T., Badou A., Flavell R. A., Mehal W. Z., Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9 Hepatology 2007 46 5 1509 1518 (Pubitemid 350155533)
46. Zu L., He J., Jiang H., Xu C., Pu S., Xu G., Bacterial endotoxin stimulates adipose lipolysis via toll-like receptor 4 and extracellular signal-regulated kinase pathway Journal of Biological Chemistry 2009 284 9 5915 5926
47. de Almeida I. T., Cortez-Pinto H., Fidalgo G., Rodrigues D., Camilo M. E., Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis Clinical Nutrition 2002 21 3 219 223 (Pubitemid 34846801)
48. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., Kopp A., Schoelmerich J., Falk W., Fatty acid-induced induction of Toll-like receptor-4/nuclear factor- B pathway in adipocytes links nutritional signalling with innate immunity Immunology 2009 126 2 233 245
49. Erridge C., Samani N. J., Saturated fatty acids do not directly stimulate toll-like receptor signaling Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 11 1944 1949
50. Vreugdenhil A. C. E., Rousseau C. H., Hartung T., Greve J. W. M., Van 't Veer C., Buurman W. A., Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons Journal of Immunology 2003 170 3 1399 1405 (Pubitemid 36139507)
51. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E., Chylomicrons promote intestinal absorption of lipopolysaccharides Journal of Lipid Research 2009 50 1 90 97
52. Imai Y., Kuba K., Neely G. G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y. H. C., Wang H., Liu H., Sun Y., Pasparakis M., Kopf M., Mech C., Bavari S., Peiris J. S. M., Slutsky A. S., Akira S., Hultqvist M., Holmdahl R., Nicholls J., Jiang C., Binder C. J., Penninger J. M., Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 2008 133 2 235 249 (Pubitemid 351512299)
53. Tsung A., Klune J. R., Zhang X., Jeyabalan G., Cao Z., Peng X., Stolz D. B., Geller D. A., Rosengart M. R., Billiar T. R., HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling Journal of Experimental Medicine 2007 204 12 2913 2923 (Pubitemid 350179560)
54. Stacey K. J., Young G. R., Clark F., Sester D. P., Roberts T. L., Naik S., Sweet M. J., Hume D. A., The molecular basis for the lack of immunostimulatory activity of vertebrate DNA Journal of Immunology 2003 170 7 3614 3620 (Pubitemid 36359230)
55. Takaoka A., Wang Z., Choi M. K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T., DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 2007 448 7152 501 505 (Pubitemid 47123520)
56. Muruve D. A., Ptrilli V., Zaiss A. K., White L. R., Clark S. A., Ross P. J., Parks R. J., Tschopp J., The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response Nature 2008 452 7183 103 107 (Pubitemid 351355095)
57. Aoki H., Ohnishi H., Hama K., Ishijima T., Satoh Y., Hanatsuka K., Ohashi A., Wada S., Miyata T., Kita H., Yamamoto H., Osawa H., Sato K., Tamada K., Yasuda H., Mashima H., Sugano K., Autocrine loop between TGF- 1 and IL-1 through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells American Journal of Physiology 2006 290 4 C1100 C1108
58. Zhang Y. P., Yao X. X., Zhao X., Interleukin-1 beta up-regulates tissue inhibitor or matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells World Journal of Gastroenterology 2006 12 9 1392 1396
59. Neyrinck A. M., Cani P. D., Dewulf E. M., De Backer F., Bindels L. B., Delzenne N. M., Critical role of Kupffer cells in the management of diet-induced diabetes and obesity Biochemical and Biophysical Research Communications 2009 385 3 351 356
60. Huang W., Metlakunta A., Dedousis N., Zhang P., Sipula I., Dube J. J., Scott D. K., O'Doherty R. M., Depletion of liver kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 2010 59 2 347 357
61. Lanthier N., Molendi-Coste O., Horsmans Y., Van Rooijen N., Cani P. D., Leclercq I. A., Kupffer cell activation is a causal factor for hepatic insulin resistance American Journal of Physiology 2010 298 1 G107 G116
62. Stienstra R., Saudale F., Duval C., Keshtkar S., Groener J. E. M., Van Rooijen N., Staels B., Kersten S., Mller M., Kupffer cells promote hepatic steatosis via interleukin-1 -dependent suppression of peroxisome proliferator-activated receptor activity Hepatology 2010 51 2 511 522
63. Clementi A. H., Gaudy A. M., van Rooijen N., Pierce R. H., Mooney R. A., Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling Biochimica et Biophysica Acta 2009 1792 11 1062 1072
64. Lanthier N., Horsmans Y., Leclercq I. A., Clodronate liposomes: all sites of injection are not equal Hepatology 2010 51 2 721 722
65. Isogawa M., Robek M. D., Furuichi Y., Chisari F. V., Toll-like receptor signaling inhibits hepatitis B virus replication in vivo Journal of Virology 2005 79 11 7269 7272 (Pubitemid 40677357)
66. Kodama Y., Taura K., Miura K., Schnabl B., Osawa Y., Brenner D. A., Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis Gastroenterology 2009 136 4 1423 1434
67. Marra F., Selective inhibition of NF- B in Kupffer cells: good, but not for everything Gut 2009 58 12 1581 1582
68. Arkan M. C., Hevener A. L., Greten F. R., Maeda S., Li Z. W., Long J. M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M., IKK- links inflammation to obesity-induced insulin resistance Nature Medicine 2005 11 2 191 198 (Pubitemid 40321355)
69. Cai D., Yuan M., Frantz D. F., Melendez P. A., Hansen L., Lee J., Shoelson S. E., Local and systemic insulin resistance resulting from hepatic activation of IKK- and NF- B Nature Medicine 2005 11 2 183 190 (Pubitemid 40321354)
70. Luedde T., Beraza N., Kotsikoris V., van Loo G., Nenci A., De Vos R., Roskams T., Trautwein C., Pasparakis M., Deletion of NEMO/IKK in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma Cancer Cell 2007 11 2 119 132 (Pubitemid 46209851)
71. Ma K. L., Ruan X. Z., Powis S. H., Chen Y., Moorhead J. F., Varghese Z., Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice Hepatology 2008 48 3 770 781
72. Hirosumi J., Tuncman G., Chang L., Grgn C. Z., Uysal K. T., Maeda K., Karin M., Hotamisligil G. S., A central, role for JNK in obesity and insulin resistance Nature 2002 420 6913 333 336 (Pubitemid 35398190)
73. Schattenberg J. M., Singh R., Wang Y., Lefkowitch J. H., Rigoli R. M., Scherer P. E., Czaja M. J., JNK1 but not JNK2 promotes the development of steatohepatitis in mice Hepatology 2006 43 1 163 172 (Pubitemid 43733603)
74. Singh R., Wang Y., Xiang Y., Tanaka K. E., Gaarde W. A., Czaja M. J., Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance Hepatology 2009 49 1 87 96
75. Solinas G., Vilcu C., Neels J. G., Bandyopadhyay G. K., Luo J. L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J. M., Karin M., JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity Cell Metabolism 2007 6 5 386 397 (Pubitemid 350012000)
76. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- : direct role in obesity-linked insulin resistance Science 1993 259 5091 87 91 (Pubitemid 23036092)
77. Hui J. M., Hodge A., Farrell G. C., Kench J. G., Kriketos A., George J., Beyond insulin resistance in NASH: TNF- or adiponectin? Hepatology 2004 40 1 46 54 (Pubitemid 38868922)
78. Salmenniemi U., Ruotsalainen E., Pihlajamki J., Vauhkonen I., Kainulainen S., Punnonen K., Vanninen E., Laakso M., Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome Circulation 2004 110 25 3842 3848 (Pubitemid 40023983)
79. Juge-Aubry C. E., Somm E., Chicheportiche R., Burger D., Pernin A., Cunod-Pittet B., Quinodoz P., Giusti V., Dayer J. M., Meier C. A., Regulatory effects of interleukin (IL)-1, interferon-, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue Journal of Clinical Endocrinology and Metabolism 2004 89 6 2652 2658 (Pubitemid 38766345)
80. Tomita K., Tamiya G., Ando S., Ohsumi K., Chiyo T., Mizutani A., Kitamura N., Toda K., Kaneko T., Horie Y., Han J. -Y., Kato S., Shimoda M., Oike Y., Tomizawa M., Makino S., Ohkura T., Saito H., Kumagai N., Nagata H., Ishii H., Hibi T., Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice Gut 2006 55 3 415 424 (Pubitemid 43268283)
81. Cawthorn W. P., Sethi J. K., TNF- and adipocyte biology FEBS Letters 2008 582 1 117 131
82. Mar M., Caballero F., Colell A., Morales A., Caballeria J., Fernandez A., Enrich C., Fernandez-Checa J. C., Garca-Ruiz C., Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis Cell Metabolism 2006 4 3 185 198 (Pubitemid 44307975)
83. Zhang W., Kudo H., Kawai K., Fujisaka S., Usui I., Sugiyama T., Tsukada K., Chen N., Takahara T., Tumor necrosis factor- accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease Biochemical and Biophysical Research Communications 2010 391 4 1731 1736
84. Jager J., Grmeaux T., Cormont M., Le Marchand-Brustel Y., Tanti J. F., Interleukin-1 -induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression Endocrinology 2007 148 1 241 251 (Pubitemid 46021456)
85. Oda K., Tanaka N., Arai T., Araki J., Song Y., Zhang L., Kuchiba A., Hosoi T., Shirasawa T., Muramatsu M., Sawabe M., Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases Human Molecular Genetics 2007 16 6 592 599 (Pubitemid 46585661)
86. Shen J., Arnett D. K., Peacock J. M., Parnell L. D., Kraja A., Hixson J. E., Tsai M. Y., Lai C. Q., Kabagambe E. K., Straka R. J., Ordovas J. M., Interleukin1 genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome Journal of Nutrition 2007 137 8 1846 1851 (Pubitemid 47292728)
87. Nozaki Y., Saibara T., Nemoto Y., Ono M., Akisawa N., Iwasaki S., Hayashi Y., Hiroi M., Enzan H., Onishi S., Polymorphisms of interleukin-1 and 3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis Alcoholism: Clinical and Experimental Research 2004 28 8 106S 110S (Pubitemid 44139570)
88. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., Asano M., Moriwaki H., Seishima M., Lack of interleukin-1 decreases the severity of atherosclerosis in apoE-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 4 656 660 (Pubitemid 36438080)
89. Osborn O., Brownell S. E., Sanchez-Alavez M., Salomon D., Gram H., Bartfai T., Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity Cytokine 2008 44 1 141 148
90. Isoda K., Sawada S., Ayaori M., Matsuki T., Horai R., Kagata Y., Miyazaki K., Kusuhara M., Okazaki M., Matsubara O., Iwakura Y., Ohsuzu F., Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice Journal of Biological Chemistry 2005 280 8 7002 7009 (Pubitemid 40341256)
91. Fujita K., Nozaki Y., Yoneda M., Wada K., Takahashi H., Kirikoshi H., Inamori M., Saito S., Iwasaki T., Terauchi Y., Maeyama S., Nakajima A., Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model Alcoholism: Clinical and Experimental Research 2010 34 1 S18 S24
92. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W., Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 2003 112 12 1796 1808 (Pubitemid 38063703)
93. Weisberg S. P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R. L., Ferrante A. W., CCR2 modulates inflammatory and metabolic effects of high-fat feeding Journal of Clinical Investigation 2006 116 1 115 124 (Pubitemid 43121796)
94. Kanda H., Tateya S., Tamori Y., Kotani KO., Hiasa K. I., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity Journal of Clinical Investigation 2006 116 6 1494 1505
95. Obstfeld A. E., Sugaru E., Thearle M., Francisco A. M., Gayet C., Ginsberg H. N., Ables E. V., Ferrante A. W., C-C Chemokine Receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis Diabetes 2010 59 4 916 925
96. Chacn M. R., Fernndez-Real J. M., Richart C., Mega A., Gmez J. M., Miranda M., Caubet E., Pastor R., Masdevall C., Vilarrasa N., Ricard W., Vendrell J., Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study Obesity 2007 15 3 664 672 (Pubitemid 46643320)
97. Clment S., Juge-Aubry C., Sgroi A., Conzelmann S., Pazienza V., Pittet-Cuenod B., Meier C. A., Negro F., Monocyte chemoattractant protein-1 secreted by adipose tissue induces direct lipid accumulation in hepatocytes Hepatology 2008 48 3 799 807
98. Li Z., Yang S., Lin H., Huang J., Watkins P. A., Moser A. B., DeSimone C., Song X. Y., Diehl A. M., Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 2003 37 2 343 350 (Pubitemid 36152533)
99. Pappo I., Bercovier H., Berry E., Gallilly R., Feigin E., Freund H. R., Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat Journal of Parenteral and Enteral Nutrition 1995 19 1 80 82
100. Barbuio R., Milanski M., Bertolo M. B., Saad M. J., Velloso L. A., Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet Journal of Endocrinology 2007 194 3 539 550 (Pubitemid 47471222)
101. Yang S. J., Iglayreger H. B., Kadouh H. C., Bodary P. F., Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy Diabetologia 2009 52 5 972 981
102. Lirussi F., Mastropasqua E., Orando S., Orlando R., Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis Cochrane Database of Systematic Reviews 2007 1, article CD005165
103. Velayudham A., Dolganiuc A., Ellis M., Petrasek J., Kodys K., Mandrekar P., Szabo G., VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice Hepatology 2009 49 3 989 997